Literature DB >> 16338458

TNFalpha-mediated induction of PAI-1 restricts invasion of HTR-8/SVneo trophoblast cells.

A V Huber1, L Saleh, S Bauer, P Husslein, M Knöfler.   

Abstract

The pro-inflammatory cytokine TNFalpha has numerous effects on placental trophoblasts. Here, we investigated the effects of the cytokine on gene expression and function of the extravillous trophoblast cell line HTR-8/SVneo. Wound healing and Matrigel invasion assays demonstrate that TNFalpha impairs motility and invasiveness. In contrast, counting of cumulative cell numbers and FACS analyses revealed that the cytokine did neither affect proliferation nor distribution of cell cycle phases. Immunocytochemistry of the cytokeratin 18 neo-epitope suggests that TNFalpha did not induce apoptosis in HTR-8/SVneo cells. Gelatine zymography and enzyme activity assays of supernatants of TNFalpha-treated cells demonstrate elevation of the pro- and active form of MMP-9 suggesting that increased expression of the protease cannot overcome the TNFalpha-inhibitory effect on cell invasion. Semi-quantitative RT-PCR analyses suggest that the cytokine may not alter mRNA levels of uPA and tPA. However, elevated expression of PAI-1 was detected by RT-PCR, as well as by Northern and Western blot analyses. Supplementation of PAI-1-blocking antibodies restored invasion of TNF-alpha-incubated HTR-8/SVneo cells through Matrigel-coated transwells. In addition, immunocytochemistry revealed nuclear accumulation of the p65 subunit of NFkappaB in the presence of the cytokine. EMSA indicated TNFalpha-induced binding of the inflammatory transcription factor to an NFkappaB consensus sequence and to the NFkappaB recognition site located in the PAI-1 promoter. The data suggest that TNFalpha restricts trophoblast invasion mainly by increasing the expression of PAI-1. Induction of the inhibitor may involve TNFalpha-stimulated activation of NFkappaB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16338458     DOI: 10.1016/j.placenta.2005.02.012

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  22 in total

1.  Interferon-γ protects first-trimester decidual cells against aberrant matrix metalloproteinases 1, 3, and 9 expression in preeclampsia.

Authors:  Charles J Lockwood; Murat Basar; Umit A Kayisli; Ozlem Guzeloglu-Kayisli; William Murk; Jenny Wang; Nicole De Paz; John P Shapiro; Rachel J Masch; Nihan Semerci; S Joseph Huang; Frederick Schatz
Journal:  Am J Pathol       Date:  2014-07-24       Impact factor: 4.307

2.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

3.  Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.

Authors:  Keiichiro Kimachi; Hiroshi Kajiya; Shuji Nakayama; Tetsuro Ikebe; Koji Okabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-12       Impact factor: 3.000

4.  CsA improves the trophoblasts invasiveness through strengthening the cross-talk of trophoblasts and decidual stromal cells mediated by CXCL12 and CD82 in early pregnancy.

Authors:  Yu-Han Meng; Jun Shao; Hui Li; Yan-Li Hou; Chuan-Ling Tang; Mei-Rong Du; Ming-Qing Li; Da-Jin Li
Journal:  Int J Clin Exp Pathol       Date:  2012-04-16

5.  Optimization of techniques for multiple platform testing in small, precious samples such as human chorionic villus sampling.

Authors:  Margareta D Pisarska; Marzieh Akhlaghpour; Bora Lee; Gillian M Barlow; Ning Xu; Erica T Wang; Aaron J Mackey; Charles R Farber; Stephen S Rich; Jerome I Rotter; Yii-der I Chen; Mark O Goodarzi; Seth Guller; John Williams
Journal:  Prenat Diagn       Date:  2016-11-07       Impact factor: 3.050

Review 6.  Molecular Cross-Talk at the Feto-Maternal Interface.

Authors:  Gendie E Lash
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

7.  Role of hypoxia-inducible transcription factors 1alpha and 2alpha in the regulation of plasminogen activator inhibitor-1 expression in a human trophoblast cell line.

Authors:  E S Meade; Y Y Ma; S Guller
Journal:  Placenta       Date:  2007-06-13       Impact factor: 3.481

Review 8.  Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.

Authors:  S Haider; M Knöfler
Journal:  Placenta       Date:  2008-11-22       Impact factor: 3.481

9.  Effect of urokinase-type plasminogen activator system in gastric cancer with peritoneal metastasis.

Authors:  Youcheng Ding; Hui Zhang; Aiguo Lu; Zhuqing Zhou; Mingan Zhong; Dongwei Shen; Xujing Wang; Zhenggang Zhu
Journal:  Oncol Lett       Date:  2016-04-26       Impact factor: 2.967

Review 10.  Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy.

Authors:  K G Pringle; K L Kind; A N Sferruzzi-Perri; J G Thompson; C T Roberts
Journal:  Hum Reprod Update       Date:  2009-11-19       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.